Related Experiment Videos
[Fetal fibronectin and preterm birth]
Zhonghua Fu Chan Ke Za Zhi
|January 1, 1997
Summary
Fetal fibronectin is a sensitive diagnostic marker for predicting preterm birth. This enzyme-labeled immunosorbent assay (ELISA) test shows a higher positive rate in women with threatened preterm delivery.
Area of Science:
- Obstetrics and Gynecology
- Biomarkers in Pregnancy
- Diagnostic Test Evaluation
Context:
- Preterm birth poses significant risks to maternal and infant health.
- Accurate prediction of preterm birth is crucial for timely intervention.
- Fetal fibronectin is a protein found in cervical secretions during pregnancy.
Purpose:
- To evaluate the diagnostic and predictive accuracy of fetal fibronectin for preterm birth.
- To assess the sensitivity of fetal fibronectin testing in women with threatened preterm delivery.
Summary:
- Fetal fibronectin was measured using enzyme-labeled immunosorbent assay (ELISA) in 38 women with threatened preterm delivery and 43 controls.
- A significantly higher positive rate of fetal fibronectin was observed in the threatened preterm delivery group.
- These findings indicate fetal fibronectin's utility in identifying at-risk pregnancies.
Impact:
- Establishes fetal fibronectin as a valuable biomarker for preterm birth diagnosis and prediction.
- Supports the clinical use of fetal fibronectin testing to improve obstetric outcomes.
- Contributes to the understanding of biochemical markers in managing high-risk pregnancies.